What Is ctDNA?

Like a mill crumbling into a river, solid tumors constantly shed bits of themselves — including their DNA — into the bloodstream. This free-floating genetic material, known as circulating tumor DNA, or ctDNA, contains a trove of information about the tumor.  Advances in technology have made it possible to extract ctDNA from a blood sample, … Read more

Patient is First at Dana-Farber to Undergo Outpatient Stem Cell Transplant for Myeloma 

In most ways, Bill Ross’s stem cell transplant for multiple myeloma at Dana-Farber Brigham Cancer Center (DFBCC) wasn’t out of the ordinary. He received chemotherapy to destroy the tumor cells in his body and then an infusion of his own hematopoietic stem cells, which flocked to his bone marrow and regenerated his blood supply. Over … Read more

Research Drives Key Protein from the Shadows to Reveal Its Role in Breast Cancer Subtype 

In a branch of the PI3K protein family — with members named PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ — PI3Kβ was long treated as the proverbial middle child: neglected by cancer scientists in favor of its more prominent siblings.  In a new study, Dana-Farber researchers demonstrate that it doesn’t deserve its obscurity — that in fact … Read more

How is Standard of Care for Cancer Treatment Determined? 

In general, standard of care is treatment accepted by medical experts for a certain type of disease and that is widely used by healthcare professionals. It is also called best practice, standard medical care, and standard therapy.  The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology lay out the recognized standards for cancer … Read more

What is HER2-Low Breast Cancer? 

One of the ways of classifying breast cancers is by the level of a protein called HER2 on the surface of tumor cells. HER2, which stands for human epidermal growth factor receptor 2, helps control how breast cells grow, divide, and repair damage.  Breast cancers marked by high levels of HER2 are known as HER2-positive … Read more

Clinical Trial Offers Lessons for Patient and Researchers 

When the time came for Jeffrey Ferreira to undergo a stem cell transplant for acute myeloid leukemia (AML), his Dana-Farber hematologist, Corey Cutler, MD, MPH, had some intriguing news: he was eligible for a clinical trial of a new approach to lowering the risk of chronic graft-versus-host disease (GVHD), a common and sometimes severe aftereffect … Read more

New Trial Is First to Explore Psychedelic-Assisted Therapy in Hospice Patients

On a wave of promising research and positive media stories, psychedelic drugs are edging closer to mainstream use for treating a variety of mental disorders. A clinical trial recently launched by Dana-Farber investigators is the first to evaluate such an agent in patients receiving hospice care. The trial, which plans to enroll 15 patients served … Read more

Autologous or Allogeneic Stem Cell Transplants: Which Will My Doctor Recommend?

Both allogeneic and autologous stem cell transplants involve treating a patient with chemotherapy followed by an infusion of blood-forming stem cells, with a goal of curing the cancer or extending the time before the disease relapses. In adults, transplants are used to treat a range of blood-related cancers, myelodysplastic syndromes, and non-malignant blood disorders. Autologous … Read more

Research Into Cellular Recycling System Reveals New Vulnerability in Pancreatic Cancer

Pancreatic cancer cells operate a recycling program that would be the envy of any municipality — but the only beneficiaries are the cells themselves. All cells in the body recycle minerals and nutrients, removing them from storage and breaking them down them for re-use. But in cancer cells, this process, known as autophagy — literally, … Read more